ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 851,55
0,69%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Pharming Group NV (PHARM)

  7. Pharming Group NV (PHARM) Actualités

PHARM

Pharming Group NV (PHARM)

Pharming Group NV
De:
Trier par:
 Showing the most relevant articles for your search:EU:PHARM
DateHeureSourceTitreSymboleSociété
24/04/202408h00GlobeNewswire Inc.Pharming Group to report first quarter 2024 financial results on May 8EU:PHARMPharming Group NV
24/04/202407h00GlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
19/04/202418h43GlobeNewswire Inc.Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
18/04/202415h04GlobeNewswire Inc.Pharming Group announces the placement of €100 million convertible bonds due 2029EU:PHARMPharming Group NV
18/04/202408h00GlobeNewswire Inc.Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
08/04/202407h00GlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
04/04/202408h30GlobeNewswire Inc.Pharming Group announces the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
04/04/202407h00GlobeNewswire Inc.Pharming Group announces the filing of its 2023 Annual Report and Form 20-FEU:PHARMPharming Group NV
03/04/202408h00GlobeNewswire Inc.Pharming Group to participate in April investor conferencesEU:PHARMPharming Group NV
14/03/202407h00GlobeNewswire Inc.Pharming Group reports fourth quarter and full year 2023 financial resultsEU:PHARMPharming Group NV
29/02/202408h00GlobeNewswire Inc.Pharming Group to report fourth quarter and full year 2023 financial results on March 14EU:PHARMPharming Group NV
08/02/202408h00GlobeNewswire Inc.Pharming Group to participate in February investor conferencesEU:PHARMPharming Group NV
08/01/202407h00GlobeNewswire Inc.Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch updateEU:PHARMPharming Group NV
13/12/202307h00GlobeNewswire Inc.Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)EU:PHARMPharming Group NV
21/11/202307h00GlobeNewswire Inc.Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisibEU:PHARMPharming Group NV
10/11/202314h51GlobeNewswire Inc.Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approvalEU:PHARMPharming Group NV
01/11/202308h00GlobeNewswire Inc.Pharming Group to participate in November investor conferencesEU:PHARMPharming Group NV
26/10/202307h00GlobeNewswire Inc.Pharming Group reports third quarter 2023 financial resultsEU:PHARMPharming Group NV
12/10/202308h00GlobeNewswire Inc.Pharming Group to report third quarter 2023 financial results on October 26EU:PHARMPharming Group NV
25/09/202316h00GlobeNewswire Inc.Pharming Group reports on results of the 2023 Extraordinary General Meeting of ShareholdersEU:PHARMPharming Group NV
25/03/202300h22Dow Jones NewsADRs End Mostly Lower, Pharming Group Trades ActivelyEU:PHARMPharming Group NV
13/03/202309h34Dow Jones NewsPharming Expects to Have Access to $26 Million It Has on Deposit at SVB USEU:PHARMPharming Group NV
23/12/202111h02Dow Jones NewsPharming Group, Sanofi Renew Strategic Manufacturing Partnership AgreementEU:PHARMPharming Group NV
01/07/202107h00GlobeNewswire Inc.Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Thera...EU:PHARMPharming Group NV
09/08/201613h20Dow Jones NewsValeant Posts a Loss, Says It Will RetoolEU:PHARMPharming Group NV
06/03/201407h13GlobeNewswire Inc.Pharming Reports On Preliminary Financial Results 2013EU:PHARMPharming Group NV
24/02/201407h12GlobeNewswire Inc.PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST(r)EU:PHARMPharming Group NV
08/11/201307h06GlobeNewswire Inc.PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST (RECOMBINANT HUMAN C1 ESTERASE I...EU:PHARMPharming Group NV
07/11/201307h10GlobeNewswire Inc.Pharming Reports On Financial Results For The First Nine Months Of 2013EU:PHARMPharming Group NV
09/10/201307h07GlobeNewswire Inc.Pharming announces EU12.0 million private equity placement with institutional investorsEU:PHARMPharming Group NV
 Showing the most relevant articles for your search:EU:PHARM

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
BN
Danone
NASDAQ
AMZN
Amazon.com
EU
LR
Legrand
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
EU
HO
Thales
NASDAQ
MSFT
Microsoft
EU
AI
Air Liquide
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés